Biohybrid Vaccines for Improved Treatment of Aggressive Melanoma with Checkpoint Inhibitor.

ACS Nano · 2019 · PMC6595659 · PMID 31100004

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Mice receiving NanoCCM showed a trend toward an increased infiltration of DCs (defined as CD11c + cells; Figure 2 B) with a large portion of those being activated and mature (CD80 and CD86 double positive cells; Figure 2 C).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.